WHOLE EXOME SEQUENCING MARKET Challenges and Opportunities

The high costs associated with whole exome sequencing and subsequent data analysis pose a major challenge for the growth of the global whole exome sequencing market. The instruments, reagents, and other consumables required for sequencing runs and analytic workflows are very expensive. Additionally, the computational infrastructure and specialized bioinformatics expertise required for processing and interpreting the massive amounts of sequencing data also contributes significantly to the overall costs.

Market Opportunity - Growing adoption of whole exome sequencing in emerging markets

The growing adoption of whole exome sequencing in emerging markets present a major opportunity for players in the global whole exome sequencing market. Countries such as China, India, Brazil, and those across Southeast Asia and Africa are experiencing rapid economic growth and increased healthcare spending. With greater affordability and accessibility, clinical adoption of advanced genomic technologies such as whole exome sequencing is gaining momentum in these developing regions.